Sign in to fuzzto save your conversations, follow your research and come back anytime.
Entero Healthcare Solutions
ENTERO
NSE
BSE
NSEBSESectorRetail
1,848.00
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Entero Healthcare drives strong revenue and profit growth with improved capital efficiency, while managing rising costs and streamlining its customer network.
EBITDA Margin expanded from 3.6% in Q1 FY26 to 5.0% in Q1 2026-27 — stronger cost control across operations
Finance Costs rose from ₹8.3 Cr in Q1 FY26 to ₹18.1 Cr in Q1 2026-27 — higher debt servicing pressure
RoCE improved from 11.5% in Q1 FY26 to 21.0% in Q1 2026-27 — better use of invested capital
Hospital Customers fell from 2,500 in Q1 FY26 to 2,300 in Q1 2026-27 — portfolio rationalization
Warehouse Locations grew from 102 in Q1 FY26 to 138 in Q1 2026-27 — faster delivery networks
Other Income declined from ₹5.6 Cr in Q1 FY26 to ₹1.6 Cr in Q1 2026-27 — reduced non-operating earnings support
NWC Days tightened from 66 days in Q1 FY26 to 61 days in Q1 2026-27 — efficient cash management
Employee Expenses increased from ₹56.7 Cr in Q1 FY26 to ₹68.7 Cr in Q1 2026-27 — workforce scaling costs
Revenue climbed from ₹1,403.8 Cr in Q1 FY26 to ₹1,940 Cr in Q1 2026-27 — consistent top-line expansion
Other Expenses climbed from ₹31.9 Cr in Q1 FY26 to ₹55.0 Cr in Q1 2026-27 — closer cost monitoring needed
